About Company
We at Polyamyna Nanotech Inc. (PNI), endeavor to develop next-generation antimicrobial technologies to prevent infections caused by deadly pathogens, especially ESKAPE bacteria, (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) molds and viruses (including human coronavirus) eventually striving to address the global pandemic and antimicrobial resistance.
